Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review.

Jiang, Yingying; Fang, Xiaoxu; Xiang, Yan; Fang, Tingwen; Liu, Jingwen; Lu, Kaihua

Jiang, Yingying; Fang, Xiaoxu; Xiang, Yan; Fang, Tingwen; Liu, Jingwen; Lu, Kaihua.

Jiang Y; Department of Oncology, Nanjing Medical University, Nanjing 210029, China.
Fang X; Department of Oncology, Nanjing Medical University, Nanjing 210029, China.
Xiang Y; Department of Oncology, Nanjing Medical University, Nanjing 210029, China.
Fang T; Department of Oncology, Nanjing Medical University, Nanjing 210029, China.
Liu J; Department of Oncology, Nanjing Medical University, Nanjing 210029, China.
Lu K; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Curr Oncol ; 30(6): 5337-5349, 2023 05 28.

Article en En | MEDLINE | ID: mdl-37366888

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Humanos; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/genética; Carcinoma de Pulmón de Células no Pequeñas/patología; Afatinib/uso terapéutico; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patología; Inhibidores de Proteínas Quinasas/efectos adversos; Receptores ErbB/genética; Mutación

Palabras clave

afatinib; epidermal growth factor receptor; non-small-cell lung cancer; rare mutations; uncommon mutations

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google